Journament

Keyword Connections - drug monitoring Keywords

Connection Type	Connection
Journals	Nanoscale American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists The Review of scientific instruments pharmacy practice the journal of political economy
Research Groups	No Research Group Connected
Bibliographies	[1] junior doctors’ preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an australian teaching hospital [2] adverse drug events in hospitals: a systematic review eventos adversos a medicamentos em hospitais: uma revisão sistemática [3] importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance [4] therapeutic drug monitoring of the newer anti-epilepsy medications [5] A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea [6] Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience [7] A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea [8] A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea [9] Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience [10] Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management [11] Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus. [12] A new HPLC-MS/MS method for simultaneous determination of Cyclosporine A, Tacrolimus, Sirolimus and Everolimus for routine therapeutic drug monitoring. [13] Therapeutic drug monitoring of cyclosporine and tacrolimus in Myanmar kidney transplant patients [14] Combined approach with therapeutic drug monitoring and pharmacogenomics in renal transplant recipients [15] Better data, better policy and better lives: a call for improved drug monitoring and concerted responses. [16] ["Drug Interaction Stewardship" (DIS) and Therapeutic Drug Monitoring for Anti-infective Treatment in Intensive Care, a Single Centre Observational Study]. [17] Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice. [18] Therapeutic Drug Monitoring of Everolimus: A Consensus Report. [19] Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring. [20] [Level of evidence for therapeutic drug monitoring of everolimus]. [21] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus. [22] Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring. [23] Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review [24] Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions. [25] the routine practice of therapeutic drug monitoring - some of the results of work in the system of chi [26] minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: an integrated approach for multidrug-resistant tuberculosis [27] therapeutic drug monitoring of the newer anti-epilepsy medications [28] population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid [29] early therapeutic drug monitoring for isoniazid and rifampin among diabetics with newly diagnosed tuberculosis in virginia, usa [30] on the road towards strategic application of therapeutic drug monitoring of mycophenolic acid in renal allograft recipients [31] Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review [32] Therapeutic drug monitoring of amikacin in septic patients [33] Therapeutic drug monitoring of anti-infective agents in critically ill patients [34] Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review [35] Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation. [36] The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure. [37] LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring. [38] Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring.